1. Home
  2. LPCN vs AIRI Comparison

LPCN vs AIRI Comparison

Compare LPCN & AIRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPCN
  • AIRI
  • Stock Information
  • Founded
  • LPCN 1997
  • AIRI 1979
  • Country
  • LPCN United States
  • AIRI United States
  • Employees
  • LPCN N/A
  • AIRI N/A
  • Industry
  • LPCN Biotechnology: Pharmaceutical Preparations
  • AIRI Military/Government/Technical
  • Sector
  • LPCN Health Care
  • AIRI Industrials
  • Exchange
  • LPCN Nasdaq
  • AIRI Nasdaq
  • Market Cap
  • LPCN 16.1M
  • AIRI 13.4M
  • IPO Year
  • LPCN N/A
  • AIRI N/A
  • Fundamental
  • Price
  • LPCN $3.10
  • AIRI $3.24
  • Analyst Decision
  • LPCN Strong Buy
  • AIRI
  • Analyst Count
  • LPCN 1
  • AIRI 0
  • Target Price
  • LPCN $10.00
  • AIRI N/A
  • AVG Volume (30 Days)
  • LPCN 10.3K
  • AIRI 12.9K
  • Earning Date
  • LPCN 05-08-2025
  • AIRI 04-15-2025
  • Dividend Yield
  • LPCN N/A
  • AIRI N/A
  • EPS Growth
  • LPCN N/A
  • AIRI N/A
  • EPS
  • LPCN N/A
  • AIRI N/A
  • Revenue
  • LPCN $11,198,144.00
  • AIRI $55,108,000.00
  • Revenue This Year
  • LPCN N/A
  • AIRI $1.80
  • Revenue Next Year
  • LPCN N/A
  • AIRI N/A
  • P/E Ratio
  • LPCN N/A
  • AIRI N/A
  • Revenue Growth
  • LPCN N/A
  • AIRI 6.97
  • 52 Week Low
  • LPCN $2.75
  • AIRI $3.00
  • 52 Week High
  • LPCN $11.79
  • AIRI $9.44
  • Technical
  • Relative Strength Index (RSI)
  • LPCN 46.56
  • AIRI 41.93
  • Support Level
  • LPCN $2.82
  • AIRI $3.02
  • Resistance Level
  • LPCN $3.27
  • AIRI $3.36
  • Average True Range (ATR)
  • LPCN 0.23
  • AIRI 0.18
  • MACD
  • LPCN 0.01
  • AIRI 0.01
  • Stochastic Oscillator
  • LPCN 58.92
  • AIRI 47.06

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

About AIRI Air Industries Group

Air Industries Group is an aerospace and defense company. Its manufactures and designs structural parts and assemblies that focus on flight safety, including landing gear, arresting gear, engine mounts, flight controls, throttle quadrants, jet engines, and other components. The company also provides sheet metal fabrication of aerostructures, tube bending, and welding services.

Share on Social Networks: